CXCL9, an Early Inflammatory Marker As Prognostic Indicator Following Allogeneic Stem Cell Transplantation: A Single Prospective cohort study

Key Points

• CXCL9 levels indicate patient outcomes following allogeneic stem cell transplantation.
• The study shows a significant correlation between CXCL9 and patient prognosis.
• Observational analysis using a prospective cohort highlighted CXCL9 as a key inflammatory marker.
• Understanding inflammatory markers like CXCL9 could improve post-transplant care strategies.